112 related articles for article (PubMed ID: 10223550)
1. Analysis of strain variation of R1 repeated structure in varicella-zoster virus DNA by polymerase chain reaction.
Yoshida M; Tamura T; Hiruma M
J Med Virol; 1999 May; 58(1):76-8. PubMed ID: 10223550
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
[TBL] [Abstract][Full Text] [Related]
3. An analytical method for R5 repeated structure in varicella-zoster virus DNA by polymerase chain reaction.
Yoshida M; Tamura T
J Virol Methods; 1999 Jul; 80(2):213-5. PubMed ID: 10471031
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of clinical varicella-zoster strains from India and differentiation from the oka vaccine strain.
Kaushik KS; Lahiri KK; Chumber SK; Gupta RM; Kumar S; Kapila K; Karade S
Jpn J Infect Dis; 2008 Jan; 61(1):65-7. PubMed ID: 18219137
[TBL] [Abstract][Full Text] [Related]
5. Analysis of repeat units in the R2 region among different Oka varicella-zoster virus vaccine strains and wild-type strains in Germany.
Sauerbrei A; Zell R; Wutzler P
Intervirology; 2007; 50(1):40-4. PubMed ID: 17164556
[TBL] [Abstract][Full Text] [Related]
6. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.
Levin MJ; DeBiasi RL; Bostik V; Schmid DS
J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373
[TBL] [Abstract][Full Text] [Related]
7. Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.
Sauerbrei A; Rubtcova E; Wutzler P; Schmid DS; Loparev VN
J Clin Microbiol; 2004 Dec; 42(12):5604-8. PubMed ID: 15583288
[TBL] [Abstract][Full Text] [Related]
8. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
[TBL] [Abstract][Full Text] [Related]
9. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
10. New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis.
Takayama M; Takayama N
J Clin Virol; 2004 Feb; 29(2):113-9. PubMed ID: 14747030
[TBL] [Abstract][Full Text] [Related]
11. Genome differences among varicella-zoster viruses isolated in Thailand.
Thawaranantha D; Balachandra K; Jongtrakulsiri S; Yamkunthong W; Chimabutra K; Bhumiswasdi J
Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):677-83. PubMed ID: 9139375
[TBL] [Abstract][Full Text] [Related]
12. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
[TBL] [Abstract][Full Text] [Related]
13. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR.
Loparev VN; Argaw T; Krause PR; Takayama M; Schmid DS
J Clin Microbiol; 2000 Sep; 38(9):3156-60. PubMed ID: 10970349
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the Oka vaccine strain of varicella-zoster virus.
Yamanishi K
J Infect Dis; 2008 Mar; 197 Suppl 2():S45-8. PubMed ID: 18419407
[TBL] [Abstract][Full Text] [Related]
15. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
Sauerbrei A; Wutzler P
J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
[TBL] [Abstract][Full Text] [Related]
16. [Application of PCR to DNA diagnosis and molecular epidemiology of varicella-zoster virus infection].
Hondo R; Inouye S; Ohsawa S; Itho S
Tanpakushitsu Kakusan Koso; 1990 Dec; 35(17):3034-40. PubMed ID: 1962869
[No Abstract] [Full Text] [Related]
17. Differentiation of wild-type varicella-zoster strains from India and the Oka vaccine strain using a VZV open reading frame - 62 based PCR-RFLP technique.
Kaushik KS; Lahiri KK; Kapila K; Kumar S; Gupta RM; Karade S
Braz J Infect Dis; 2008 Aug; 12(4):313-5. PubMed ID: 19030732
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between vaccine and wild-type varicella-zoster virus genotypes by high-resolution melt analysis of single nucleotide polymorphisms.
Toi CS; Dwyer DE
J Clin Virol; 2008 Sep; 43(1):18-24. PubMed ID: 18479962
[TBL] [Abstract][Full Text] [Related]
19. Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster.
Suzuki K; Yoshikawa T; Tomitaka A; Matsunaga K; Asano Y
J Infect Dis; 2004 Mar; 189(6):1009-12. PubMed ID: 14999603
[TBL] [Abstract][Full Text] [Related]
20. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004.
Lopez AS; Burnett-Hartman A; Nambiar R; Ritz L; Owens P; Loparev VN; Guris D; Schmid DS
J Infect Dis; 2008 Mar; 197(5):646-53. PubMed ID: 18260757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]